At West Idaho iMedCare, we offer a physician-supervised medical weight loss program using GLP agonists to support safe and sustainable weight loss. Treatment plans are individualized and focused on long-term health, lifestyle changes, and medical oversight.
Semaglutide
GLP-1 receptor agonist
Helps reduce appetite adn slow gastric emptying
Suppports blood sugar regulation
Average weight loss of approximately 15%
Administered as a weekly injection
Tirzepatide
GLP-1 and GIP receptor agonist
Enhanceces steiety and suppports metabolic health
Supports glucose and insulin balance
Average weight loss of approximately 22%
Administered as a weekly injection
Important information:
Weight loss results vary by individual and depend on dose, adherence, lifestyle factors, and medical conditions
Page updated
Report abuse